BiotechTube

Low Dose TP-05 + High Dose TP-05 + Placebo Comparator

Phase 2Completed
0 watching 0 views this week⚡ Active
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Healthy Volunteer

Conditions

Healthy Volunteer

Trial Timeline

Dec 12, 2022 → Jun 26, 2024

NCT ID
NCT05387083

About Low Dose TP-05 + High Dose TP-05 + Placebo Comparator

Low Dose TP-05 + High Dose TP-05 + Placebo Comparator is a phase 2 stage product being developed by Tarsus Pharmaceuticals for Healthy Volunteer. The current trial status is completed. This product is registered under clinical trial identifier NCT05387083. Target conditions include Healthy Volunteer.

Hype Score Breakdown

Clinical
17
Activity
12
Company
5
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT05387083Phase 2Completed

Competing Products

20 competing products in Healthy Volunteer

See all competitors
ProductCompanyStageHype Score
AZD0837AstraZenecaPhase 1
33
ValsartanNovartisPhase 1
33
CSL112 + PlaceboCSLPhase 1
32
UT-15CUnited TherapeuticsPhase 1
30
VNA-318 + PlaceboBiotrialPhase 1
25
Open-label TRV734 125 mg + TRV734 blinded + Oxycodone IR 10 mg + PlaceboTrevenaPhase 1
25
TRV130 + Moxifloxacin + PlaceboTrevenaPhase 1
25
Radiolabeled TRV130TrevenaPhase 1
25
TRV130A + Dextrose in WaterTrevenaPhase 1
25
TRV734TrevenaPhase 1
25
ALT02 + EU-licensed Herceptin + US-licensed HerceptinAlteogenPhase 1
33
ENZ215 + EU Sourced Prolia + US Sourced ProliaAlkem LaboratoriesPhase 1
33
KPL-404Kiniksa PharmaceuticalsPhase 1
28
MORF-057 + Placebo for MORF-057Eli LillyPhase 1
33
Propranolol + PseudoephedrineEli LillyPre-clinical
23
LY2157299Eli LillyPhase 1
33
Lasmiditan + PlaceboEli LillyPhase 1
33
LY3015014 + PlaceboEli LillyPhase 1
33
LOXO-783Eli LillyPhase 1
33
LY2541546 - IV + LY2541546 - SC + PlaceboEli LillyPhase 1
33

Other Products from Tarsus Pharmaceuticals

Lotilaner ophthalmic solution, 0.25% + Vehicle controlApproved
80
TP-03 + TP-03 VehiclePhase 3
72
TP-03, 0.25% + TP-03 VehiclePhase 2/3
60
Vehicle of TP-03Phase 2
47
Lotilaner Gel, 2.0%Phase 2
47